AAAAAA
Results:
1-17
|
Results: 17
Authors:
Alain, C
Cortese, F
Bernstein, LJ
He, Y
Zipursky, RB
Citation: C. Alain et al., Auditory feature conjunction in patients with schizophrenia, SCHIZOPHR R, 49(1-2), 2001, pp. 179-191
Authors:
Sullivan, EV
Fama, R
Shear, PK
Cahn-Weiner, DA
Stein, M
Zipursky, RB
Pfefferbaum, A
Citation: Ev. Sullivan et al., Motor sequencing deficits in schizophrenia: A comparison with Parkinson's disease, NEUROPSYCHL, 15(3), 2001, pp. 342-350
Authors:
Verhoeff, NPLG
Kapur, S
Hussey, D
Lee, M
Christensen, B
Papatheodorou, G
Zipursky, RB
Citation: Nplg. Verhoeff et al., A simple method to measure baseline occupancy of neostriatal dopamine D-2 receptors by dopamine in vivo in healthy subjects, NEUROPSYCH, 25(2), 2001, pp. 213-223
Authors:
Silvestri, S
Seaman, MV
Negrete, JC
Houle, S
Shammi, CM
Remington, GJ
Kapur, S
Zipursky, RB
Wilson, AA
Christensen, BK
Seeman, P
Citation: S. Silvestri et al., Increased dopamine D-2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study, PSYCHOPHAR, 152(2), 2000, pp. 174-180
Authors:
Fitzgerald, PB
Kapur, S
Remington, G
Roy, P
Zipursky, RB
Citation: Pb. Fitzgerald et al., Predicting haloperidol occupancy of central dopamine D-2 receptors from plasma levels, PSYCHOPHAR, 149(1), 2000, pp. 1-5
Authors:
Verhoeff, NPLG
Meyer, JH
Kecojevic, A
Hussey, D
Lewis, R
Tauscher, J
Zipursky, RB
Kapur, S
Citation: Nplg. Verhoeff et al., A voxel-by-voxel analysis of [F-18]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia, PSYCH RES-N, 99(3), 2000, pp. 123-135
Authors:
Fitzgerald, PB
Kapur, S
Caligiuri, MP
Jones, C
Silvestri, S
Remington, G
Zipursky, RB
Citation: Pb. Fitzgerald et al., Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D-2 blockade, NEUROPSYCH, 22(1), 2000, pp. 19-26
Authors:
Zipursky, RB
Citation: Rb. Zipursky, Untitled - Introduction, SCHIZOPHR R, 35(3), 1999, pp. 187-187
Authors:
Zipursky, RB
Darby, P
Citation: Rb. Zipursky et P. Darby, Placebo-controlled studies in schizophrenia - ethical and scientific perspectives: an overview of conference proceedings, SCHIZOPHR R, 35(3), 1999, pp. 189-200
Authors:
Zhang-Wong, J
Zipursky, RB
Beiser, M
Bean, G
Citation: J. Zhang-wong et al., Optimal haloperidol dosage in first-episode psychosis, CAN J PSY, 44(2), 1999, pp. 164-167
Authors:
Zipursky, RB
Citation: Rb. Zipursky, Ethics in psychiatric research: A resource manual for human subjects protection., J NERV MENT, 187(10), 1999, pp. 642-644
Authors:
Chow, EWC
Mikulis, DJ
Zipursky, RB
Scutt, LE
Weksberg, R
Bassett, AS
Citation: Ewc. Chow et al., Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia, BIOL PSYCHI, 46(10), 1999, pp. 1436-1442
Authors:
Kapur, S
Cho, R
Jones, C
McKay, G
Zipursky, RB
Citation: S. Kapur et al., Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine(2) and serotonin(2) occupancy, BIOL PSYCHI, 45(9), 1999, pp. 1217-1220
Authors:
Zipursky, RB
Kapur, S
Citation: Rb. Zipursky et S. Kapur, Structural brain changes in schizophrenia - In reply, ARCH G PSYC, 56(2), 1999, pp. 195-196
Authors:
Kapur, S
Zipursky, RB
Remington, G
Citation: S. Kapur et al., Clinical and theoretical implications of 5-HT2 and D-2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia, AM J PSYCHI, 156(2), 1999, pp. 286-293
Authors:
Lewis, R
Kapur, S
Jones, C
DaSilva, J
Brown, GM
Wilson, AA
Houle, S
Zipursky, RB
Citation: R. Lewis et al., Serotonin 5-HT2 receptors in schizophrenia: A PET study using [F-18]setoperone in neuroleptic-naive patients and normal subjects, AM J PSYCHI, 156(1), 1999, pp. 72-78
Authors:
Zhang-Wong, JH
Beiser, M
Zipursky, RB
Bean, G
Citation: Jh. Zhang-wong et al., An investigation of ethnic and gender differences in the pharmacodynamics of haloperidol, PSYCHIAT R, 81(3), 1998, pp. 333-339
Risultati:
1-17
|